Neurocrine Biosciences, Inc. - Laporan Laba Rugi (TTM)

Neurocrine Biosciences, Inc.
DE ˙ DB ˙ US64125C1099
€ 122.20 ↑1.15 (0.95%)
2025-09-10
BAHAGING PRESYO
Laporan Laba Rugi (TTM)

Laporan Laba Rugi Neurocrine Biosciences, Inc. menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 1,042 1,046 1,045 1,032 1,069 1,134 1,208 1,297 1,389 1,489 1,598 1,673 1,784 1,887 1,982 2,120 2,243 2,355 2,413 2,510
Change (%) 0.36 -0.05 -1.29 3.63 5.99 6.53 7.40 7.09 7.20 7.38 4.66 6.63 5.79 5.03 6.94 5.82 5.02 2.43 4.03
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 273 285 301 295 320 342 373 436 453 487 528 545 584 605 624 667 716 765 871 926
Change (%) 4.32 5.51 -1.80 8.50 6.83 8.97 16.83 3.88 7.55 8.46 3.14 7.27 3.47 3.13 6.90 7.44 6.83 13.79 6.35
% of Revenue 26.23 27.26 28.77 28.63 29.97 30.21 30.90 33.61 32.61 32.71 33.04 32.56 32.76 32.04 31.46 31.45 31.93 32.48 36.09 36.89
Gross Operating Profit 769 761 745 736 749 791 834 861 936 1,002 1,070 1,128 1,200 1,282 1,358 1,453 1,527 1,590 1,542 1,584
Change (%) -1.04 -2.13 -1.09 1.68 5.63 5.47 3.18 8.71 7.03 6.85 5.41 6.32 6.91 5.93 6.96 5.07 4.17 -3.03 2.72
% of Revenue 73.77 72.74 71.23 71.37 70.03 69.79 69.10 66.39 67.39 67.29 66.96 67.44 67.24 67.96 68.54 68.55 68.07 67.52 63.91 63.11
SG&A 428 433 444 491 533 583 655 695 726 753 795 834 852 888 888 908 938 1,007 1,041 1,085
Change (%) 1.21 2.58 10.51 8.57 9.38 12.29 6.05 4.56 3.63 5.58 4.91 2.15 4.23 0.05 2.27 3.31 7.34 3.32 4.26
% of Revenue 41.08 41.43 42.52 47.60 49.87 51.46 54.24 53.56 52.30 50.56 49.72 49.83 47.74 47.04 44.80 42.85 41.84 42.76 43.13 43.22
R&D
Change (%)
% of Revenue
OpEx 701 718 745 787 854 926 1,028 1,130 1,179 1,240 1,323 1,378 1,436 1,492 1,512 1,575 1,654 1,772 1,911 2,011
Change (%) 2.42 3.74 5.54 8.54 8.42 11.06 9.96 4.30 5.14 6.71 4.20 4.17 3.92 1.29 4.18 5.06 7.12 7.84 5.21
% of Revenue 67.31 68.69 71.29 76.23 79.84 81.67 85.14 87.18 84.91 83.27 82.76 82.40 80.50 79.08 76.27 74.30 73.77 75.25 79.22 80.11
Operating Income 341 328 300 245 216 208 179 166 210 249 276 294 348 395 470 545 588 583 501 499
Change (%) -3.87 -8.37 -18.26 -12.11 -3.62 -13.67 -7.30 26.04 18.80 10.68 6.86 18.13 13.48 19.15 15.80 8.00 -0.90 -14.00 -0.46
% of Revenue 32.69 31.31 28.71 23.77 20.16 18.33 14.86 12.82 15.09 16.73 17.24 17.60 19.50 20.92 23.73 25.70 26.23 24.75 20.78 19.89
Interest Expense -33 -33 -31 -29 -27 -26 -22 -18 -13 -6 -2 -1
Change (%) -1.20 -5.49 -6.77 -6.57 -4.44 -14.73 -18.18 -30.00 -58.93 -52.17
% of Revenue -3.19 -3.14 -2.97 -2.80 -2.52 -2.28 -1.82 -1.39 -0.91 -0.35 -0.14 -0.06
Net Income 93 407 402 365 445 90 71 12 58 154 64 176 191 250 370 339 386 341 306 348
Change (%) 336.08 -1.30 -9.28 21.96 -79.86 -20.31 -82.91 377.05 165.46 -58.58 175.62 8.28 30.73 48.06 -8.25 13.77 -11.56 -10.40 13.90
% of Revenue 8.96 38.94 38.45 35.34 41.59 7.90 5.91 0.94 4.19 10.38 4.00 10.54 10.71 13.23 18.65 16.00 17.21 14.49 12.68 13.88

Source: Capital IQ

Other Listings
IT:1NBIX € 106.55
US:NBIX US$ 141.25
GB:0K6R
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista